Skip to main content
. Author manuscript; available in PMC: 2012 Jul 17.
Published in final edited form as: Genes Chromosomes Cancer. 2010 Aug;49(8):711–725. doi: 10.1002/gcc.20784

TABLE 1.

Results of the Comparison of Amplification Between OPN5 and 6p21.2 Genes

>2
>3
OPN5 OPN5
2/573 (0.3%) p, Chi-sq 0 p, Fisher
BTBD9 9/530 (1.7%) 2.43E-02 2/530 (0.4%) 1.42E-01
GLO1 49/536 (8.4%) 2.59E-11 14/577 (2.4%) 2.10E-04
DNAH8 30/568 (5.0%) 9.70E-07 5/595 (0.8%) 2.85E-02
GLP1R 26/532 (4.7) 3.41E-06 7/551 (1.3%) 7.16E-03
C6orf64 16/589 (2.6%) 1.34E-03 3/602 (0.5%) 9.15E-02
KCNK5 15/557 (2.6%) 1.45E-03 2/570 (0.3%) 1.58E-01
KCNK17 26/520 (4.8%) 1.32E-06 5/541 (0.9%) 2.19E-02
KCNK16 11/546 (2.0%) 1.02E-02 3/554 (0.5%) 1.33E-02
C6orf102 7/576 (1.2%) 9.90E-02 2/586 (0.3%) 1.63E-01
DAAM2 8/598 (1.3%) 6.83E-02 3/604 (0.5%) 5.18E-02

In this table the frequencies of amplification (for threshold of >2-fold and >3-fold) of genes mapping to the amplicon on 6p21.2 are listed together with the statistical significance of the difference between amplification frequencies of OPN5 and respective genes. P-values significant after Benjamini-Hochberg correction with a FDR of 10% are indicated in bold. The amplification frequencies were calculated as ratios of the number of samples with amplification confirmed in two independent experiments and the total number of informative samples.